Mechanism of Binding of Prothioconazole to Mycosphaerella graminicola CYP51 Differs from That of Other Azole Antifungals
Open Access
- 15 February 2011
- journal article
- Published by American Society for Microbiology in Applied and Environmental Microbiology
- Vol. 77 (4) , 1460-1465
Abstract
Prothioconazole is one of the most important commercially available demethylase inhibitors (DMIs) used to treat Mycosphaerella graminicola infection of wheat, but specific information regarding its mode of action is not available in the scientific literature. Treatment of wild-type M. graminicola (strain IPO323) with 5 μg of epoxiconazole, tebuconazole, triadimenol, or prothioconazole ml −1 resulted in inhibition of M. graminicola CYP51 (MgCYP51), as evidenced by the accumulation of 14α-methylated sterol substrates (lanosterol and eburicol) and the depletion of ergosterol in azole-treated cells. Successful expression of MgCYP51 in Escherichia coli enabled us to conduct spectrophotometric assays using purified 62-kDa MgCYP51 protein. Antifungal-binding studies revealed that epoxiconazole, tebuconazole, and triadimenol all bound tightly to MgCYP51, producing strong type II difference spectra (peak at 423 to 429 nm and trough at 406 to 409 nm) indicative of the formation of classical low-spin sixth-ligand complexes. Interaction of prothioconazole with MgCYP51 exhibited a novel spectrum with a peak and trough observed at 410 nm and 428 nm, respectively, indicating a different mechanism of inhibition. Prothioconazole bound to MgCYP51 with 840-fold less affinity than epoxiconazole and, unlike epoxiconazole, tebuconazole, and triadimenol, which are noncompetitive inhibitors, prothioconazole was found to be a competitive inhibitor of substrate binding. This represents the first study to validate the effect of prothioconazole on the sterol composition of M. graminicola and the first on the successful heterologous expression of active MgCYP51 protein. The binding affinity studies documented here provide novel insights into the interaction of MgCYP51 with DMIs, especially for the new triazolinethione derivative prothioconazole.Keywords
This publication has 34 references indexed in Scilit:
- Heterologous Expression of Mutated Eburicol 14α-Demethylase (CYP51) Proteins of Mycosphaerella graminicola To Assess Effects on Azole Fungicide Sensitivity and Intrinsic Protein FunctionApplied and Environmental Microbiology, 2010
- Structural Basis of Human CYP51 Inhibition by Antifungal AzolesJournal of Molecular Biology, 2010
- Crystal Structures of Trypanosoma brucei Sterol 14α-Demethylase and Implications for Selective Treatment of Human InfectionsJournal of Biological Chemistry, 2010
- Sterol content analysis suggests altered eburicol 14α-demethylase (CYP51) activity in isolates ofMycosphaerella graminicolaadapted to azole fungicidesFEMS Microbiology Letters, 2009
- Expression and functional characterization of cytochrome P450 26A1, a retinoic acid hydroxylaseBiochemical Pharmacology, 2009
- Purification and characterization of bovine steroid 21-hydroxylase (P450c21) efficiently expressed in Escherichia coliBiochemical and Biophysical Research Communications, 2006
- The Cytochrome P450 Complement (CYPome) of Streptomyces coelicolor A3(2)Journal of Biological Chemistry, 2002
- Inhibition of Sterol Biosynthesis in Candida albicans by Imidazole-containing AntifungalsMicrobiology, 1980
- Inhibition of ergosterol synthesis in Ustilago maydis by the fungicide triarimolBiochemical and Biophysical Research Communications, 1972
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970